Home › Compare › SCNLF vs MCD

SCNLF vs MCD: Dividend Comparison 2026

SCNLF yields 1373.63% · MCD yields 2.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCNLF wins by $315919182.70M in total portfolio value
10 years
SCNLF
SCNLF
● Live price
1373.63%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$315919182.78M
Annual income
$276,344,297,604,930.75
Full SCNLF calculator →
MCD
McDonald's Corporation
● Live price
2.34%
Share price
$310.79
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$25,833.37
Full MCD calculator →

Portfolio growth — SCNLF vs MCD

📍 SCNLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCNLFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCNLF + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SCNLF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCNLF
Annual income on $10K today (after 15% tax)
$116,758.24/yr
After 10yr DRIP, annual income (after tax)
$234,892,652,964,191.12/yr
MCD
Annual income on $10K today (after 15% tax)
$198.56/yr
After 10yr DRIP, annual income (after tax)
$21,958.36/yr
At 15% tax rate, SCNLF beats the other by $234,892,652,942,232.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCNLF + MCD for your $10,000?

SCNLF: 50%MCD: 50%
100% MCD50/50100% SCNLF
Portfolio after 10yr
$157959591.43M
Annual income
$138,172,148,815,382.06/yr
Blended yield
87.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

SCNLF
No analyst data
Altman Z
-12.0
Piotroski
2/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+13.2% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCNLF buys
0
MCD buys
0
No recent congressional trades found for SCNLF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCNLFMCD
Forward yield1373.63% ✓2.34%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$315919182.78M ✓$77.7K
Annual income after 10y$276,344,297,604,930.75 ✓$25,833.37
Total dividends collected$313011682.66M ✓$57.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: SCNLF vs MCD ($10,000, DRIP)

YearSCNLF PortfolioSCNLF Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$148,063$137,362.64$10,812$332.41+$137.3K → SCNLF
2$2,059,200$1,900,773.30$11,819$488.02+$2.05M → SCNLF
3$26,909,187$24,705,842.24$13,111$724.37+$26.90M → SCNLF
4$330,522,388$301,729,558.78$14,832$1,091.05+$330.51M → SCNLF
5$3,817,312,082$3,463,653,126.46$17,219$1,675.85+$3817.29M → SCNLF
6$41,470,385,979$37,385,862,050.80$20,688$2,641.85+$41470.37M → SCNLF
7$423,953,934,089$379,580,621,092.34$25,990$4,309.70+$423953.91M → SCNLF
8$4,080,240,641,140$3,626,609,931,664.44$34,590$7,351.77+$4080240.61M → SCNLF
9$36,985,873,996,458$32,620,016,510,437.74$49,535$13,285.25+$36985873.95M → SCNLF
10$315,919,182,781,141$276,344,297,604,930.75$77,746$25,833.37+$315919182.70M → SCNLF

SCNLF vs MCD: Complete Analysis 2026

SCNLF — Stock

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, an ImmunoBody cancer vaccine for the treatment of metastatic melanoma; SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumours, including non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

Full SCNLF Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this SCNLF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCNLF vs SCHDSCNLF vs JEPISCNLF vs OSCNLF vs KOSCNLF vs MAINSCNLF vs YUMSCNLF vs QSRSCNLF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.